Institutional investors purchased a net $1.2 million shares of MDCO during the quarter ended March 2016 and now own 119.56% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 463.0 Thousand shares of Medicines Co
JPMORGAN SECURITIES LLC Bought 425.3 Thousand shares of Medicines Co
CAMBER CAPITAL MANAGEMENT LLC Bought 300.0 Thousand shares of Medicines Co